• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ESBF3614C103E
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 09/10/2025
Type of Reportable Event Serious Injury
Event or Problem Description
A endurant iis stent graft system was implanted during the endovascular treatment of a 58mm abdominal aortic aneurysm.It was reported that a final contrast angiogram revealed a type ia endoleak involving the esbf3614c103e bifurcate stent graft.An endurant cuff (etcf3636c49e) was placed to treat the endoleak and was deployed without issue.However, during removal of the endurant cuff delivery system, the spindle caught the stent struts, pulling one of the struts downward and causing it to remain in this position.Multiple unsuccessful attempts were made to reposition the stent strut using a 12mm balloon and a reliant balloon.Since the type ia endoleak was resolved, the physician completed the procedure without further issues.Per the physician, the cause of the events was anatomy related due to an angled and conical infrarenal aortic neck.No additional sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Product analysis conclusion: the reported type ia endoleak and suprarenal stent deformation were confirmed on the films provided; however, the cause of the event could not be conclusively determined.The difficulty removing the delivery system could not be confirmed.The exact moment of stent deployment and removal of the delivery system after cuff implantation were not available for review.It is possible that the angulated and conical neck contributed to the type ia endoleak and removal difficulty leading to suprarenal stent deformation; however, this could not be confirmed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key23050517
Report Number9612164-2025-04563
Device Sequence Number15830648
Product Code MIH
UDI-Device Identifier00643169439955
UDI-Public(01)00643169439955(17)270515
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberESBF3614C103E
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/10/2025
Supplement Date Received by Manufacturer10/31/2025
Initial Report FDA Received Date09/15/2025
Supplement Report FDA Received Date11/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age61 YR
Patient SexMale
-
-